Diabetic Macular Edema Treatment Limits in Poland

• Autorzy: Jarosław Pinkas , Rafał Muc , Anna Radziwilska-Muc , Iwona Grabska-Liberek
• Języki publikacji: EN

Abstrakty

EN

Diabetic Macular Edema (DME) is a severe disease, related to Diabetic Retinopathy (DR). All diabetic patients are at risk of DME development. The disease severity may vary from mild to moderate, with a risk of loss of vision. Diabetic Retinopathy, including Diabetic Macular Edema patients in Poland, are treated within Diagnosis Related Groups (JGP) system, that allows settlement of costs of performed medical procedures, including vitreoretinal procedures, fotocoagulation, and administration of VEGF inhibitors. In this article authors tried to analyse what are the costs of treatment of DME patients within Diagnosis Related Groups (JGP) in Poland, what are the trends in expenditures of DME treatment, and what are the recommended steps to the decision makers in vision loss prevention amongst mellitus patients in Poland? The study and analyses in this article are based on Diagnosis Related Groups (JGP) statistical reports available for years 2009-2015, published by the Polish National Health Fund (NFZ). DME treatment spendings within the JGP groups in Poland, are notably low, vary from 1,2 MM PLN in 2009, achieving its maximum of 1,5MM PLN in 2010, and resulting in <1,1 MM PLN in year 2015. The number of treated patients decreased markedly from more than 800 in year 2009, achieving its minimum of 198 patients in year 2014. DME treatment in Poland within the public system is remarkably below needs, and it does not meet standards of vision loss prevention amongst mellitus patients. The situation is mainly caused by under-diagnosis at the primary healthcare outpatient clinics, long waiting time for an ophthalmologist consultations and treatment budget limits within JGP groups in hospitals(original abstract)

Słowa kluczowe

EN

Health service; Medicine; Health care

PL

Służba zdrowia; Medycyna; Opieka zdrowotna

• Czasopismo: Journal of Health Policy and Outcomes Research
• Rocznik: 2016
• Numer: nr 1
• Strony: 47--52

Twórcy

autor

Jarosław Pinkas

• Centre of Postgraduate Medical Education

autor

Rafał Muc

• University of Economics, Poznań, Executive MBA at Koźmiński University, Warsaw

autor

Anna Radziwilska-Muc

• Nikolaus Copernicus University in Toruń

autor

Iwona Grabska-Liberek

• President of Polish Ophthalmology Society Head of Ophthalmology Clinic Postgraduate Centre of Medical Education

Bibliografia

• Khan BU, Lam W-C.: Macular Edema in Diabetes. Available at: http://emedicine.medscape.com/article/1224138-overview

Identyfikatory

DOI

10.7365/JHPOR.2016.1.8